Advances in the treatment of inherited coagulation disorders.

Advances in the treatment of inherited coagulation disorders.

Item
http://www.wikidata.org/entity/Q38100271
A missense variant in CST3 exerts a recessive effect on susceptibility to age-related macular degeneration resembling its association with Alzheimer's disease.Predictors of quality of life among adolescents and young adults with a bleeding disorderNovel products for haemostasis.Industrial production of clotting factors: Challenges of expression, and choice of host cells.Intracranial Hemorrhage as the First Manifestation of Severe Congenital Factor X Deficiency in a 20-Month-Old Male: Case Report and Review of the Literature.Plasma-derived human factor X concentrate for on-demand and perioperative treatment in factor X-deficient patients: pharmacology, pharmacokinetics, efficacy, and safety.Engineering trypsin for inhibitor resistance.Coping in adult patients with severe haemophilia.[Factor XIII : Pharmacodynamic and pharmacokinetic characteristics].
P2860

Advances in the treatment of inherited coagulation disorders.

Item
http://www.wikidata.org/entity/Q38100271
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Advances in the treatment of inherited coagulation disorders.
@en
type
label
Advances in the treatment of inherited coagulation disorders.
@en
prefLabel
Advances in the treatment of inherited coagulation disorders.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Advances in the treatment of inherited coagulation disorders.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698